The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Pauwels Eric since 2014.
This trader's CIK number is 1323212.
At the time of last reporting, Pauwels Eric was the CHIEF BUSINESS OFFICER of Ptc Therapeutics, Inc.. (stock ticker symbol PTCT).
Also see all insider trading activities at Ptc Therapeutics, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2015 | NPSP | 0 | $0 | 0 | $0 | 10,887 | $0 |
2014 | NPSP | 0 | $0 | 0 | $0 | 9,767 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | PTCT | 0 | $0 | 17,900 | $946,326 | 0 | $0 |
2024 | PTCT | 0 | $0 | 4,787 | $134,605 | 0 | $0 |
2023 | PTCT | 0 | $0 | 19,217 | $1,104,989 | 0 | $0 |
2022 | PTCT | 0 | $0 | 3,220 | $130,278 | 0 | $0 |
2021 | PTCT | 0 | $0 | 2,646 | $151,771 | 0 | $0 |
2020 | PTCT | 0 | $0 | 6,194 | $349,961 | 0 | $0 |
1. Nps Pharmaceuticals Inc (NPSP)
2. Ptc Therapeutics, Inc. (PTCT)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2015-02-12 | NPSP | Option Ex | 2,787 | .00 | 0 |
2015-02-13 | NPSP | Option Ex | 8,100 | .00 | 0 |
2014-08-01 | NPSP | Option Ex | 1,667 | .00 | 0 |
2014-02-13 | NPSP | Option Ex | 8,100 | .00 | 0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-03-14 | PTCT | Sale | 4,458 | 55.19 | 246,037 |
2025-03-17 | PTCT | Sale | 6,762 | 56.96 | 385,163 |
2025-02-19 | PTCT | Sale | 1,378 | 50.10 | 69,032 |
2025-02-20 | PTCT | Sale | 1,567 | 50.12 | 78,544 |
2025-01-07 | PTCT | Sale | 1,599 | 45.34 | 72,498 |
2025-01-08 | PTCT | Sale | 2,136 | 44.50 | 95,052 |
2024-04-17 | PTCT | Sale | 787 | 25.14 | 19,781 |
2024-01-30 | PTCT | Sale | 366 | 27.25 | 9,973 |
2024-01-08 | PTCT | Sale | 1,569 | 28.64 | 44,936 |
2024-01-09 | PTCT | Sale | 2,065 | 29.02 | 59,915 |
2023-05-22 | PTCT | Sale | 2,013 | 59.32 | 119,409 |
2023-05-19 | PTCT | Sale | 6,403 | 58.95 | 377,488 |
2023-05-17 | PTCT | Sale | 8,048 | 58.51 | 470,880 |
2023-05-18 | PTCT | Sale | 788 | 58.71 | 46,266 |
2023-04-18 | PTCT | Sale | 732 | 52.04 | 38,096 |
2023-01-31 | PTCT | Sale | 375 | 45.63 | 17,110 |
2023-01-09 | PTCT | Sale | 858 | 41.66 | 35,740 |
2022-04-19 | PTCT | Sale | 822 | 42.52 | 34,947 |
2022-02-01 | PTCT | Sale | 367 | 40.00 | 14,680 |
2022-01-25 | PTCT | Sale | 359 | 39.31 | 14,113 |
2022-01-07 | PTCT | Sale | 866 | 38.52 | 33,362 |
2022-01-04 | PTCT | Sale | 806 | 41.16 | 33,176 |
2021-04-19 | PTCT | Sale | 786 | 48.17 | 37,860 |
2021-02-01 | PTCT | Sale | 362 | 56.96 | 20,618 |
2021-01-25 | PTCT | Sale | 431 | 62.05 | 26,745 |
2021-01-05 | PTCT | Sale | 1,067 | 62.37 | 66,548 |
2020-11-03 | PTCT | Sale | 6,194 | 56.50 | 349,961 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Pauwels Eric (CHIEF BUSINESS OFFICER of Ptc Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.